Effect of zonisamide on lipid peroxidationKOMATSU, M; HIRAMATSU, M; ENDO, A et al.Neurosciences (Okayama). 1995, Vol 21, pp P63-P66, issn 0388-7448, SUPConference Paper

Clinical pharmacology of lamotriginePECK, A. W.Epilepsia (Copenhagen). 1991, Vol 32, pp S9-S12, issn 0013-9580, SUP2Conference Paper

Neurochemical and behavioral aspects of lamotrigineLEACH, M. J; BAXTER, M. G; CRITCHLEY, M. A. E et al.Epilepsia (Copenhagen). 1991, Vol 32, pp S4-S8, issn 0013-9580, SUP2Conference Paper

Prevention of hyperthermia-induced seizures in immature rats by a hydantoin derivative of naloxoneCHATTERJIE, N; LAORDEN, M. L; PUIG, M. M et al.Life sciences (1973). 1989, Vol 45, Num 10, pp 857-862, issn 0024-3205, 6 p.Article

Anticonvulsant phosphorus analogs of GABACATES, L. A.Drug development research. 1985, Vol 5, Num 4, pp 395-399, issn 0272-4391Article

Pharmacological evaluation of various metabolites and analogues of valproic acidLOSCHER, W; NAU, H.Neuropharmacology. 1985, Vol 24, Num 5, pp 427-435, issn 0028-3908Article

When the antiepileptic drugs are not workingLEACH, John Paul.Practical neurology (Print). 2009, Vol 9, Num 1, pp 27-32, issn 1474-7758, 6 p.Article

Human safety of lamotrigineBETTS, T; GOODWIN, G; WITHERS, R. M et al.Epilepsia (Copenhagen). 1991, Vol 32, pp S17-S21, issn 0013-9580, SUP2Conference Paper

Overview of the clinical efficacy of lamotrigineRICHENS, A; YUEN, A. W. C.Epilepsia (Copenhagen). 1991, Vol 32, pp S13-S16, issn 0013-9580, SUP2Conference Paper

Vigabatrin therapy in patient with succinic semialdehyde dehydrogenase deficiencyGIBSON, K. M; DEVIVO, D. C; JAKOBS, C et al.Lancet (British edition). 1989, Vol 2, Num 8671, pp 1105-1106, issn 0140-6736, 2 p.Article

Zur Valenz leistungspsychologischer Parameter bei Einstellung auf Finlepsin und convulsofin = Paramètre psychologique de l'efficacité de la finlepsine et de la convulsofine = For valence by the introduction of finlepsin and convulsofin of efficiency psychological parameterKONIG, K; TSCHUSCHKE, D.Psychiatrie, Neurologie und medizinische Psychologie. 1987, Vol 39, Num 1, pp 44-48, issn 0033-2739Article

Surveillance thérapeutique du phénobarbital et de la diphénylhydantoineBAGREL, D; SIEST, G.SYNTHESE MEDICALE. 1987, Num 7, pp 2-7, 2 p.Article

Amphetamine as a protective agent against oxygen-induced convulsions in miceCRIBORN, C. O; CLEMEDSON, C.-J; HENRIKSSON, C et al.Aviation, space, and environmental medicine. 1986, Vol 57, Num 8, pp 777-781, issn 0095-6562Article

Therapeutic monitoring of antiepileptic drugs. II: Analytical techniquesALBANI, F; RIVA, R; BARUZZI, A et al.Il Farmaco (Pavia). 1992, Vol 47, Num 5, pp 671-680, issn 0014-827X, SUPConference Paper

Effects of carbamazepine and its epoxide metabolite on amygdala-kindled seizures in ratsALBRIGHT, P. S; BRUNI, J.Neurology. 1984, Vol 34, Num 10, pp 1383-1386, issn 0028-3878Article

The anticonvulsant and proconvulsant effects of α₂-ADRENORECEPTOR agonists are mediated by distinct populations of α_2A-ADRENORECEPTORSSZOT, P; LESTER, M; LAUGHLIN, M. L et al.Neuroscience. 2004, Vol 126, Num 3, pp 795-803, issn 0306-4522, 9 p.Article

Carbamazepine induced vasculitisHARATS, N; SHALIT, M.Journal of neurology, neurosurgery and psychiatry. 1987, Vol 50, Num 9, pp 1241-1243, issn 0022-3050Article

Dose-independent pharmacokinetics of trimethadione and its metabolite in ratsTANAKA, E; YOSHIDA, T; KUROIWA, Y et al.Journal of pharmaceutical sciences. 1985, Vol 74, Num 3, pp 340-341, issn 0022-3549Article

Dosages de la théophylline, du phénobarbital et de l'acide valproïque par techniques chromatographiques et immunologiques = Chromatographic and immunologic assays for theophylline, phenobarbital and valproic acidVINCON, G; DEMOTES-MAINARD, F; BISTUE, C et al.Journal de pharmacie clinique (Paris). 1985, Vol 4, pp 119-126, issn 0291-1981, h. sér. 1Article

Génériques des médicaments antiépileptiques : Neurologie = GenericsMAEDER-INGVAR, M; FOLETTI, G. B.Revue médicale suisse. 2010, Vol 6, Num 247, pp 907-909, issn 1660-9379, 3 p.Article

Synthesis of aryl semicarbazones as potential anticonvulsant agentsYOGEESWARI, P; SRIRAM, D; VEENA, V et al.Biomedicine & pharmacotherapy. 2005, Vol 59, Num 1-2, pp 51-55, issn 0753-3322, 5 p.Article

Role of theapeutic drug monitoring (TDM) in pediatric anti-convulsant drug dosingWALSON, P. D.Brain & development (Tokyo. 1979). 1994, Vol 16, Num 1, pp 23-26, issn 0387-7604Article

Elevated serum creatinine levels in three patients treated with phenacemideDUGGAN, E; HOFFMAN, L; BASKA, R. E et al.Drug intelligence & clinical pharmacy. 1986, Vol 20, Num 3, pp 225-228, issn 0012-6578Article

Pharmacological response of systemically derived focal epileptic lesionsREMLER, M. P; SIGVARDT, K; MARCUSSEN, W. H et al.Epilepsia (Copenhagen). 1986, Vol 27, Num 6, pp 671-677, issn 0013-9580Article

Antagonism of picrotoxin against the taming effect of carbamazepine on footshock induced fighting behavior in miceNAKAO, K; HIGASHIO, T; INUKAI, T et al.Japanese journal of pharmacology. 1985, Vol 39, Num 2, pp 281-283, issn 0021-5198Article